Apogenix.com - Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases
Hier klicken
um zu Voten!
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
- Platzierung
- Noch nicht platziert
- Votes
- Noch keine erhalten
- Beliebt seit
- 20.03.2010
Informationen zur Webseite
| Domain | apogenix.com |
|---|---|
| Homepage URL | http://apogenix.com |
| Keywords | cancer malignant diseases oncology oncological hematology hematological protein therapeutics apg101 glioblastoma phase ii trial study efficacy solid tumors myelodysplastic syndromes mds i cd95 ligand inhibitors apg880 trail receptor agonists technology platform tumor necrosis factor superfamily tnfsf immunotherapy cancer immunotherapy checkpoint inhibitor clinical development research brain tumor |
| Sprache | englisch |